Commit Biologics closes $60M Seed financing, led by Ackermans & van Haaren with participation from AbbVie Ventures and others. The funds will advance the development of their immune engager programs.
Amount Raised
$60 Million
Round Type
Seed
Investors
Description
Commit Biologics, a Copenhagen-based biotech firm, has successfully closed a $60 million Seed financing round. The funding round was led by Ackermans & van Haaren, alongside participation from AbbVie Ventures and other investors. Commit Biologics plans to use these funds for completing IND-enabling activities and expanding their pipeline. The company's focus is on developing novel immunotherapies for various diseases.
Quick answer
Commit Biologics raised $60 Million in a Seed round, dated November 17, 2026. Investors: Novo Holdings, Korys, Bioqube Ventures, M Ventures, AbbVie Ventures and Ackermans & Van Haaren. Commit Biologics is based in Aarhus, Central Denmark Region, Denmark.
- How much did Commit Biologics raise?
- Commit Biologics raised $60 Million in a Seed round on November 17, 2026.
- Who invested in Commit Biologics?
- Novo Holdings, Korys, Bioqube Ventures, M Ventures, AbbVie Ventures and Ackermans & Van Haaren are named as investors in this round.
- What does Commit Biologics do?
- Commit Biologics is a company specializing in activating the complement system to treat cancer and autoimmune diseases using their unique Bispecific Complement Engaging (BiCE™) platform.
- Where is Commit Biologics based and how big is it?
- Commit Biologics is based in Aarhus, Central Denmark Region, Denmark. Fundz records about 20 employees.
- Who are the decision-makers at Commit Biologics?
- Fundz holds 1 contact at Commit Biologics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Commit Biologics that raised within 45 days of this round, from Fundz verified event records.
- Seawolf Therapeutics raised $100M (Seed) on November 16, 2026.
- 201 Therapeutics raised $178K (Seed) on November 16, 2026.
- Yicura BioMed raised an undisclosed amount (Series B) on November 13, 2026.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- VectorY raised $83M on November 11, 2026.
Who to call at Commit Biologics, and when
A new round usually means Commit Biologics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Commit Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Commit Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Commit Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Commit Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Commit Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.